期刊文献+

曲美他嗪治疗不稳定心绞痛的疗效评价

Trimetazidine Evaluate the Efficacy of the Treatment of Unstable Angina
下载PDF
导出
摘要 目的探讨不稳定心绞痛采用曲美他嗪进行临床治疗的效果。方法随机选取我院2010年-2012年收治的50例不稳定型心绞痛患者,分成对照组与观察组,对照组通过常规方法进行治疗,观察组在对照组治疗基础上添加曲美他嗪进行治疗,患者在治疗过程中出现心绞痛发作的则采用硝酸甘油片剂治疗,对患者的硝酸甘油消耗量、心绞痛发作频率进行记录。结果观察组患者硝酸甘油消耗量、心绞痛发作频率明显少于对照组;心电图改善情况明显优于对照组,两组数据对比具有统计学差异(P〈0.05)。结论不稳定型心绞痛患者通过曲美他嗪与常规方式相互结合治疗能够明显提高治疗效果,且没有严重不良反应,具有极大的应用价值。 Objective To study the unstable angina pectoris using the effect of trimetazidine for clinical treatment. Methods Randomly selected from our hospital in 2010 - 2012 were 50 patients with unstable angina, were divided into control group and observation group, control group treated by conventional method, the observation group was treated in the control group on the basis of added trimetazidine treatment, patients in the treatment of angina pectoris attack appeared in the process of using nitroglycerin tablet treatment, the patient of nitroglycerin consumption, frequency of angina pectofis attack. Results The observation group of patients with nitroglycerin consumption, frequency of angina pectoris attack less than control group obviously; Electrocardiogram improvement was better than control group, compared two groups of data with statistical difference (P〈0.05).Conclusion The patients with unstable angina treated by trimetazidine mutual combination of conventional way can significantly improve the treatment effect, and no serious adverse reaction, it has great application value.
作者 于桂霞
机构地区 苍山县人民医院
出处 《中国医药指南》 2013年第31期47-48,共2页 Guide of China Medicine
关键词 不稳定型心绞痛 曲美他嗪 临床效果 Unstable angina Trimetazidine Clinical effect
  • 相关文献

参考文献4

二级参考文献25

  • 1滕尧文.曲美他嗪治疗不稳定型心绞痛的疗效评价[J].中国心血管病研究,2005,3(3):212-213. 被引量:31
  • 2刘淑芳.低分子肝素治疗急性冠状动脉综合征患者的疗效观察[J].医学研究通讯,2005,34(3):36-37. 被引量:8
  • 3宫伟民,宫军芳,汤建民.曲美他嗪治疗25例不稳定型心绞痛的临床观察[J].现代医药卫生,2005,21(16):2129-2130. 被引量:22
  • 4无.慢性稳定性心绞痛诊断与治疗指南[J].中华心血管病杂志,2007,35(3):195-206. 被引量:2064
  • 5Kuralay F, Atekin E, YazlarAS, et al. Suppression of angioplasty-related inflammtion by preprocedural treatment with trimetazidine. Tohoku J Exp Med,2006, 208(3) :203-212.
  • 6Palerini T, Sangiorgi D,M arzocchi A,et al. Impact of acute coronary syndromes on two year clinical outcomes in patients with unprotected left main coronary artery stenosis treated with drug-eluting stents [J ] Am J Cardiol,2010,105(2): 174-178.
  • 7Thadani U. Selection of optimal therapy for chronic stable angina [J]. Curr Treat Options Cardiovasc Med,2006,8(1):23-35.
  • 8Kantor PF,Lucien A,Kozak R,et al.The antianginal drug trimetazidineshifts cardiac energy metabolism from fatty acid oxidation to glucoseoxidation by inhibiting mitochondrial long-chain3-ketoacyl coenzyme Athiolase[J].Circ Res,2000,86(5):580-588.
  • 9Eugene B,Elliott M,John W,et al.ACC/AHA guidelines for the manage-ment of patients with unstable angina and non-ST-segment elevation my-ocardial infarction:executive summary and recommendtions[J].Circula-tion,2000,102(5):1193-1209.
  • 10Menown. Contemporary management of coronary heart disease[J].R Coll Physicians Edinb,2010,40(1):44-47.

共引文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部